| Cervical N (%) | Oral N (%) | P-value comparing cervical and oral HPV prevalence |
---|---|---|---|
HIV + (n = 115) | |||
Overall | |||
  Positive | 51 (44.4) | 17 (14.8) | < 0.0001 |
  Negative | 64 (55.6) | 98 (85.2) |  |
High-Risk HPV | |||
  Positive | 23 (20.0) | 7 (6.1) | 0.0028 |
  Negative | 92 (80.0) | 108 (94.0) |  |
Low-Risk HPV | |||
  Positive | 37 (32.2) | 9 (7.8) | < 0.0001 |
  Negative | 78 (67.8) | 106 (92.2) |  |
Universal HPV | |||
  Positive | 17 (14.8) | 7 (6.1) | 0.028 |
  Negative | 98 (85.2) | 108 (93.9) |  |
Multiple types Infections | |||
   Positive | 28 (24.3) | 5 (4.4) | < 0.0001 |
  Negative | 87 (75.7) | 110 (95.6) |  |
HIV - (n = 139) | |||
Overall | |||
  Positive | 52 (37.4) | 13 (9.4) | < 0.0001 |
  Negative | 87 (62.6) | 126 (90.6) |  |
High-Risk HPV | |||
  Positive | 33 (23.7) | 5 (3.6) | < 0.0001 |
  Negative | 106 (76.3) | 134 (96.4) |  |
Low-Risk HPV | |||
  Positive | 29 (20.9) | 5 (3.6) | < 0.0001 |
  Negative | 110 (79.1) | 134 (96.4) |  |
Universal HPV | |||
  Positive | 22 (15.8) | 4 (2.9) | 0.0003 |
  Negative | 117 (84.2) | 135 (97.1) |  |
Multiple types infections | |||
  Positive | 29 (20.9) | 4 (2.9) |  |
  Negative | 110 (79.1) | 135 (97.1) | < 0.0001 |